The Hugo patient-centered health-data-sharing platform successfully aggregated EHR, pharmacy, personal digital device, and patient-reported outcome data for 59 patients over an 8-week period.
Cohort (n=60)
Yes
Does a patient-centered health-data-sharing platform successfully aggregate multiple real-world data sources in patients undergoing bariatric surgery or atrial fibrillation ablation?
A patient-centered health-data-sharing platform can feasibly aggregate real-world data from EHRs, pharmacies, wearables, and PROMs to monitor post-procedural recovery.
Real-world data sources, including electronic health records (EHRs) and personal digital device data, are increasingly available, but are often siloed and cannot be easily integrated for clinical, research, or regulatory purposes. We conducted a prospective cohort study of 60 patients undergoing bariatric surgery or catheter-based atrial fibrillation ablation at two U.S. tertiary care hospitals, testing the feasibility of using a patient-centered health-data-sharing platform to obtain and aggregate health data from multiple sources. We successfully obtained EHR data for all patients at both hospitals, as well as from ten additional health systems, which were successfully aggregated with pharmacy data obtained for patients using CVS or Walgreens pharmacies; personal digital device data from activity monitors, digital weight scales, and single-lead ECGs, and patient-reported outcome measure data obtained through surveys to assess post-procedure recovery and disease-specific symptoms. A patient-centered health-data-sharing platform successfully aggregated data from multiple sources.
Dhruva et al. (Mon,) conducted a cohort in Bariatric surgery or catheter-based atrial fibrillation ablation (n=60). Hugo patient-centered health-data-sharing platform was evaluated on Feasibility of aggregating multiple real-world data sources (EHR, pharmacy, personal digital devices, PROMs). The Hugo patient-centered health-data-sharing platform successfully aggregated EHR, pharmacy, personal digital device, and patient-reported outcome data for 59 patients over an 8-week period.